PharmaBoardroom

Canada: Federal Consultations on a National Strategy for Rare…

Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health Canada's consultation with Canadians on…

Mexico: On the Brink of Becoming the World’s Largest Legal…

Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational marijuana. With a population of nearly 130…

Novavax: From No-Hoper to COVID-19 Vaccine Saviour?

From almost being de-listed by the NASDAQ stock index in 2018 due to poor financial performance, US vaccine firm Novavax has completed a remarkable…

Brazil’s Largest Private Pharma Company Under Threat

Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and most populous nation in Latin…

Accelerated Regulatory Assessment of Innovative Medicines in…

Writing in the March edition of DIA’s Global Forum magazine, EMD Serono's Ana Padua outlines the findings of a recent study into accelerated…

The COVID-19 Vaccine Rush: Nationalism, Access & IP Issues

The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding supply at the expense of poorer…

Nicolas Fischer – CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using…

Alessandro Riva – CEO, Ichnos Sciences

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

Nawal Roy – Founder & CEO, Holmusk

Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment of behavioural health disorders…

Public Insurance Coverage for Rare Disease Patients in China:…

Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the findings of the first ever analysis into…

Italy: Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik…

The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine contracts, glass vial manufacturer…

Japan PMDA New Drug Approvals 2020

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below for the Japanese PMDA's new drug…

Tagged with